Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-05

FDA Approved: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' fixed-dose combination of abacavir, lamivudine, and zidovudine (abacavir/lamivudine/zidovudine) for HIV infection under an o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abacavir, Lamivudine and Zidovudine (abacavir, lamivudine and zidovudine)

Snippet

ORIG AP for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE (ABACAVIR , LAMIVUDINE AND ZIDOVUDINE)